A Landscape of Artificial Intelligence (AI) In Pharmaceutical R&D

Where you find opportunities to grow

* Can't find your brand, product, service? Join BPT Marketplace

Globavir Biosciences

Globavir Biosciences is a San Francisco Bay Area based company committed to the development of therapeutics and diagnostics for the treatment of global infectious diseases. Globavir's development strategy harnesses the advantages offered by the 505(b)2 regulatory pathway, allowing for rapid development of new therapies.

Globavir is initially focused on the treatment of dengue virus infection, a potentially lethal disease infecting 390 million patients annually. Through the combination of our proprietary diagnostic technology and advanced therapeutic candidates, Globavir is ideally positioned to rapidly impact the clinical landscape for Dengue patients.

Globavir's platform discovery technologies have further identified candidate compounds with efficacy in additional viral indications, including West Nile, Japanese Encephalitis, Ebola, Marburg, and Hunta viruses.

Founded
2011
Status
Private company
Geography
United States of America based
Funding
$7.500 M

Products

No products posted yet

Services

No services posted yet